Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

During the Trading Day
1.79 -0.21 / -10.50%
Data as of 4:04pm ET
Day’s Change
During After-Hours   Switch to standard view »
1.79 0.00 / 0.00%
Volume: 547.00
Health Technology

Company Description

Navidea Biopharmaceuticals, Inc. develops and commercializes precision diagnostics and radiopharmaceutical agents, which are intended to improve diagnostic accuracy, clinical decision-making and patient care. Its current radiopharmaceutical development programs include Lymphoseek, AZD4694 and RIGScan agents, which are used in treating various tumor cancers. The company's primary focus in to improve surgery outcomes by using market-leading gamma detection devices in combination with radiopharmaceutical agents. The company was founded in 1983 and is headquartered in Dublin, OH.

Contact Information

Navidea Biopharmaceuticals, Inc.
425 Metro Place North
Dublin Ohio 43017-1367
P:(614) 793-7500
Investor Relations:
(614) 822-2330



Mutual fund holders8.08%
Other institutional29.04%
Individual stakeholders11.22%

Top Executives

Ricardo J. GonzalezChief Executive Officer
Thomas H. TulipPresident & Chief Business Officer
Brent L. LarsonCFO, Secretary, Treasurer & Executive VP
Frederick O. CopeChief Scientific Officer & Senior Vice President
Cornelia B. ReiningerChief Medical Officer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.